LIMD1 anticorps (N-Term)
Aperçu rapide pour LIMD1 anticorps (N-Term) (ABIN928393)
Antigène
Voir toutes LIMD1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Souris, Rat (Rattus), Chien, Grenouille
-
Purification
- Purified
-
Immunogène
- LIMD1 antibody was raised in rabbit using the N terminal of LIMD1 as the immunogen
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator.
-
Commentaires
-
LIMD1 Blocking Peptide, (ABIN5614456), is also available for use as a blocking control in assays to test for specificity of this LIMD1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- LIMD1 (LIM Domains Containing 1 (LIMD1))
-
Autre désignation
- LIMD1
-
Sujet
- LIMD1 may be involved in cell anchoring via focal adhesions and in the cell cycle, particularly during mitosis. LIMD1 functionally interacts with pRB and the loss of which promotes lung carcinogenesis. Some breast tumors also have altered expression of LIMD1 RNA. LIMD1 may represent a critical tumor suppressor gene. Synonyms: Polyclonal LIMD1 antibody, Anti-LIMD1 antibody, LIM domains containing 1 antibody.
-
Pathways
- Ribonucleoprotein Complex Subunit Organization
Antigène
-